GlobeNewswire

Alipay brings enhanced "cashless" experience for Chinese tourists in the Principality of Monaco

Dela
  • Alipay and Government of Monaco signed MoU to promote mobile payment across the state
  • Hotels, restaurants, spas, luxury stores and souvenir shops already onboarded on the Alipay platform

LONDON, June 27, 2017 (GLOBE NEWSWIRE) -- Alipay, the world's largest online and mobile payment platform operated by Ant Financial Services Group ("Ant Financial", "Ant"), today announced that it has signed a MoU with the Government of Monaco, which will enable merchants in Monaco to accept payment via Alipay, giving Chinese tourists the same convenient payment experience that they enjoy at home.

Douglas Feagin, President of International Business, Ant Financial Services Group, said, "As part of our globalization strategy, we are focused on working with local partners to bring a seamless Alipay mobile payment experience to Chinese tourists, no matter where they go. The MoU makes Monaco the 12th country in Europe to accept Alipay, and we are very excited to launch the platform in the principality in collaboration with the Government of Monaco and our banking partner BNP Paribas."

H.E Mr Serge Telle, the Prime Minister of Principality of Monaco, said, "The future is becoming cashless, and China is increasingly leading the market in mobile payment innovations. It is exciting that these frictionless payment methods are available to our Chinese visitors for the first time and we look forward to seeing this partnership come to fruition."

The MoU was agreed at a signing ceremony attended by senior dignitaries and business figures:

  • Douglas Feagin, President of International Business, Ant Financial Services Group
  • H.E Mr Serge Telle, the Prime Minister of Principality of Monaco
  • Bernard D'Alessandri, CEO, Monaco Yacht Club
  • Gilbert Schweitzer, CEO, Monacair
  • Jean Luc Biamonti, CEO, Monte-Carlo Société des Bains de Mer
  • Didier Boidin, COO, Monte-Carlo Société des Bains de Mer
  • Serge Ethuin CEO, Métropole Hotel
  • Xavier Rugeroni, General Manager and Régional Vice President, Fairmont Hotel, Monte Carlo

Over ten merchants in Monaco are already accepting Alipay, including Monte-Carlo Société des Bains de Mer with 4 hotels (Hôtel de Paris Monte-Carlo, Hotel Hermitage Monte-Carlo, Monte-Carlo Bay Hotel and Resort, Monte-Carlo Beach), 3 spas including Thermes Marins Monte-Carlo, souvenir and gifts shops, and restaurants and bars. Alipay is also accepted by Monacair, Monaco's V.I.P. helicopter airline and official supplier to S.A.S. the Sovereign Prince of Monaco. Merchants who may onboard with the platform in the coming months include the Monaco Yacht Club, Metropole Hotel, and the Fairmont Hotel.

BNP Paribas, one of Alipay's key partners in Europe, enables merchants to accept Alipay across Monaco.

The agreement was brokered by Stelitt, which has partnered with Ant Financial in marketing Alipay in Monaco and France.

Pascal Do, CEO of Stelitt added: "Tourism accounts for 12% - 15% of GDP in Monaco and is a major driver of the economy. We are happy to connect Monaco and Alipay; making it easier for Chinese visitors to purchase souvenirs and experiences in a cashless way is a win-win."

Alipay is now accepted by more than eight million merchants across China and 120 thousand bricks-and-mortar shops overseas. Ant Financial has a number of key collaborations in Europe through its network of local acquirers including BNP Paribas, Barclays, Concardis, Ingenico, SIX, UniCredit, SIX, and Wirecard.

About Alipay
Operated by Ant Financial Services Group, Alipay is the world's leading mobile and online payment platform. Launched in 2004, Alipay currently has over 450 million active users and over 400 financial institution partners. Alipay has evolved from a digital wallet to a lifestyle enabler. Users can hail a taxi, book a hotel, buy movie tickets, pay utility bills, make appointments with doctors, or purchase wealth management products directly from within the app. In addition to online payments, Alipay is expanding to in-store offline payments both inside and outside of China. Over 8 million brick-and-mortar merchants now accept Alipay across China. Alipay's in-store payment service is covering more than 120,000 retail stores across the world, and tax reimbursement via Alipay is supported in 24 countries and regions. Alipay works with over 200 overseas financial institutions and payment solution providers to enable cross-border payments for Chinese travelling overseas and overseas customers who purchase products from Chinese e-commerce sites. Alipay currently supports 19 currencies. 

About Ant Financial
Ant Financial Services Group is focused on serving small and micro enterprises, as well as individuals. With the vision "bring the world equal opportunities," Ant Financial is dedicated to building an open ecosystem of Internet thinking and technologies while working with other financial institutions to support the future financial needs of society. Businesses operated by Ant Financial Services Group include Alipay, Ant Fortune, Zhima Credit and MYbank.

For more information on Ant Financial, please visit our website at www.antgroup.com; or follow us on Twitter @AntFinancial.

Media Enquiries
Ant Financial
Xinyun Yang
xinyun.yang@antfin.com
+86 138 1689 6301



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ant Financial Services Group via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum